Clinical Trial

Serum Talin-1 and Cripto-1 in Colorectal Cancer

Name: Serum Talin-1 and Cripto-1 in Colorectal Cancer — clinical trial record (NCT07414082)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Talin-1/CR-1

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The goals of this study are * To evaluate the clinical utility of Talin-1 and Cripto-1 measurement in colorectal cancer patients in comparison with healthy controls. * To Compare the diagnostic significance of serum Talin-1 and Cripto-1 with traditional serum biomarker CEA

Trial Details

NCT Number	NCT07414082
Lead Sponsor	Assiut University
Conditions	Colo-rectal Cancer
Enrollment	70 participants
Start Date	2026-03-30
Primary Completion	2028-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-17